Get the Stockscreener App
0.3827
0.38%
-0.0132
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.3827, with a volume of 365.30K.
It is down -0.38% in the last 24 hours and up +11.31% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.3695
Open:
$0.3691
24h Volume:
365.30K
Relative Volume:
0.19
Market Cap:
$15.29M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-0.6075
EPS:
-0.63
Net Cash Flow:
$-13.77M
1W Performance:
+14.89%
1M Performance:
+11.31%
6M Performance:
-53.15%
1Y Performance:
-92.85%
1-Day Range:
$0.3541
$0.3868
1-Week Range:
$0.3202
$0.395
52-Week Range:
$0.2179
$5.19
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.3681 | 14.95M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
396.48 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
188.96 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
514.34 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.03 | 31.59B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
138.85 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
ProPhase Labs’ Earnings Call: Strategic Moves Amid Challenges - TipRanks
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Reports Q1 2025 Earnings and Strategic Developments - TipRanks
Transcript : ProPhase Labs, Inc., Q1 2025 Earnings Call, May 20, 2025 - marketscreener.com
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: ProPhase Labs beats Q1 2025 EPS forecast, stock rises - Investing.com
ProPhase Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com Canada
Prophase Labs Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery - GuruFocus
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery | PRPH Stock News - GuruFocus
ProPhase (PRPH) Explores Strategic Sale of Nebula Genomics | PRPH Stock News - GuruFocus
ProPhase Labs (PRPH) Anticipates Extension for Nasdaq Listing | PRPH Stock News - GuruFocus
PRPH Streamlines Operations with Strategic Changes | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months E - GuruFocus
ProPhase Labs Inc Reports Q1 2025 EPS of $(0.13) and Revenue of $1.4 Million, Missing Estimates - GuruFocus
ProPhase Labs (PRPH) Focuses on Strategic Growth Amid Revenue De - GuruFocus
PROPHASE LABS Earnings Results: $PRPH Reports Quarterly Earnings - Nasdaq
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 - GlobeNewswire
ProPhase Labs Slashes Costs by $8M, Reveals Three Major Value Drivers Including Potential $50M Collection - Stock Titan
ProPhase Labs Delays Form 10-Q Filing - TipRanks
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 - GlobeNewswire
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Bought by Renaissance Technologies LLC - Defense World
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
Geode Capital Management LLC Boosts Stake in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
PRPH’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
There is no doubt that ProPhase Labs Inc (PRPH) ticks all the boxes. - Sete News
Metric Analysis: ProPhase Labs Inc (PRPH)’s Key Ratios in the Limelight - DWinneX
What was ProPhase Labs Inc (PRPH)’s performance in the last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
ProPhase Labs Inc (PRPH) is a good investment, but the stock may be overvalued - uspostnews.com
Daily Market Movement: ProPhase Labs Inc (PRPH) Sees a 0.54 Increase, Closing at 0.35 - DWinneX
Monitoring ProPhase Labs Inc (PRPH) after recent insider movements - knoxdaily.com
ProPhase Labs Inc (PRPH) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Investors Take Advantage Of 7.67% Gain In ProPhase Labs Inc (NASDAQ: PRPH) - Stocksregister
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
ProPhase Labs, Inc. (NASDAQ:PRPH) Short Interest Up 50.0% in March - Defense World
ProPhase Labs Closes $23.6M Asset Sale to Streamline Business Strategy - citybuzz -
ProPhase Labs Inc (NASDAQ: PRPH): Forecast Weak In 2025, Up -95.29% - Stocksregister
HighTower Advisors LLC Acquires 57,736 Shares of ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges By GuruFocus - Investing.com Canada
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
A Tale of Resilience: ProPhase Labs Inc Amid Stock Market Turbulence - investchronicle.com
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Delays Yearly Report Filing - TipRanks
Prophase Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ProPhase Labs, Inc. SEC 10-K Report - TradingView
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.92%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):